← back to search

Ali Talebi

KU Leuven · BE
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer research, Lipid metabolism, Medicine, Biology, Cancer cell, and Cancer.
h-index
citations
2,735
works
13
NIH funding
primary concept
email

Recent publications

Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer
Nature Communications 2024cited by 17position: middledoi
Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma
Journal of Clinical Investigation 2023cited by 34position: middledoi
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Journal of Experimental & Clinical Cancer Research 2023cited by 22position: firstdoi
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
Nature Communications 2022cited by 44position: middledoi
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Developmental Cell 2021cited by 759position: middledoi
Regulatory T cell differentiation is controlled by αKG-induced alterations in mitochondrial metabolism and lipid homeostasis
Cell Reports 2021cited by 109position: middledoi
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Advanced Drug Delivery Reviews 2020cited by 632position: middledoi
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer
Cancer & Metabolism 2020cited by 118position: middledoi
Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
Nature 2019cited by 478position: middledoi
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
Nature Communications 2018cited by 148position: firstdoi
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity
Gut 2018cited by 98position: middledoi
Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism
Cancer Cell 2016cited by 197position: middledoi
Identification of drugs that restore primary cilium expression in cancer cells
Oncotarget 2016cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Johannes V. Swinnen · KU Leuven9 papers (2016–2024)Jonas Dehairs · KU Leuven7 papers (2016–2024)Sarah‐Maria Fendt · VIB-KU Leuven Center for Cancer Biology5 papers (2018–2023)Frank Vanderhoydonc · KU Leuven4 papers (2016–2024)Vincent de Laat · KU Leuven3 papers (2020–2024)Tania Roskams · KU Leuven3 papers (2018–2024)Patrizia Agostinis · KU Leuven2 papers (2018–2023)Mélanie Planque · KU Leuven2 papers (2022–2023)David Nittner · VIB-KU Leuven Center for Cancer Biology2 papers (2018–2023)Aljosja Rogiers · Merck & Co., Inc., Rahway, NJ, USA (United States)2 papers (2018–2023)João Duarte · KU Leuven2 papers (2018–2022)Jean‐Christophe Marine · Cancer Research UK2 papers (2018–2023)Florian Rambow · Heinrich Heine University Düsseldorf2 papers (2018–2023)Anna Sablina · VIB-KU Leuven Center for Cancer Biology2 papers (2016–2024)Xander Spotbeen · KU Leuven2 papers (2023–2024)Tom Vanden Berghe · University of Antwerp1 papers (2024–2024)Thierry Gustot · University of Padua1 papers (2018–2018)Rajeshwar P. Mookerjee · University College London1 papers (2018–2018)Sonia V. del Rincón · McGill University Health Centre1 papers (2023–2023) · 1 papers (2020–2020)